Autonomous IP Layer

Built for the
Future of AI and IP

Autonomous IP Layer

Own and monetize your IP in an AI-driven world

Own and monetize your IP in an
AI-driven world  

BACKED BY WORLD
CLASS INVESTORS

THESIS

Camp Network is a Layer-1 blockchain built to modernize intellectual property infrastructure and power the next generation of 
AI Agents on verifiable IP.

AI is rewriting the rules of the internet and outpacing the growth of systems that protect creators. Camp is building the foundation for a new creative economy - where creators can truly own, share, and monetize their IP.

VALUES

Core beliefs that
shape our vision

DECORATION PILL

LOREM IPSUM

01

Own

Give users control over their IP in an AI-native world.

02

Share

Enable AI agents to train on user-owned IP across a global IP registry.

03

Monetize

Ensure all participants capture and monetize the value they generate.

PRODUCT

Built for the AI agent economy

The Camp Network
Testnet is now live

1095302

Confirmations

100

Nodes

459823

Blocks

START exploring

ecosystem

Creating a global IP repository

50+

LOREM IPSUM DOLOR

160

LOREM IPSUM DOLOR

95%

LOREM IPSUM DOLOR

“Camp’s infrastructure is unlocking use cases we couldn’t build anywhere else. From training recommendation agents with richer data to enabling collaborative IP attribution for crowdfunding, Camp is powering the next generation of media experiences.”

ANNOUNCEMENTS

Stay updated
with our latest

View all Articles

Camp Announces $15M Series A Fundraise

Camp is excited to announce its $15M series A led by Blockchain Capital and 1kx, with participation from dao5, Lattice, TrueBridge, Maven 11, Hypersphere, OKX, and others.

READ ARTICLE

IP includes patents, copyrights, trademarks, and trade secrets. Formally, it refers to the rights granted to creations of the mind...

READ ARTICLE

AI Remixes Reality:
The Battle for Ownership Rights

Imagine a world where your creative works—be it a song, a piece of art, or your unique fashion sense—are no longer under your...

READ ARTICLE

INVESTORS

Backed by the best

ANOTHER PILL

LOREM IPSUM